Every kratom product must be accompanied by a clear label that provides adequate information for safe and effective use by consumers including, but not limited to:

1. (1) a list of the ingredients used in the manufacture of the product;
2. (2) the amount of mitragynine and 7-hydroxymitragynine contained in the product;
3. (3) the recommended serving size of the product;
4. (4) the number of servings per container;
5. (5) the name and the principal street address of the vendor or the person responsible for distributing the product;
6. (6) any precautionary statements as to the safety and effectiveness of the product;
7. (7) a statement that the product is not intended to diagnose, treat, cure, or prevent any medical condition or disease; and
8. (8) a statement that the sale or transfer of the product to a person under twenty-one years of age is prohibited.

HISTORY: 2025 Act No. 35 (S.221), SECTION 1, eff July 11, 2025.